MedTrace Logo

Raw Banana Flour-Enriched Muffins for Hypertensive Patients

NCT07145710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-09-05

No results posted yet for this study

Summary

This study evaluated the effects of raw banana flour (RBF)-enriched muffins on hypertensive patients in Lahore, Pakistan. A total of 34 patients were divided into three groups: a control group and two intervention groups receiving muffins with 35% (C1) or 40% (C2) RBF for 10 weeks. Sensory evaluation showed high acceptability of the 35% RBF muffins, comparable to control muffins. Clinical outcomes indicated that both intervention groups experienced improvements in body weight, BMI, blood pressure, liver enzymes, and lipid profiles, with more pronounced benefits observed in the 40% RBF group. The findings suggest that RBF-enriched muffins, particularly at 40% substitution, can offer functional, nutritional, and clinical benefits for individuals with hypertension.

Conditions

  • Hypertension (HTN)
  • Lipid Profile
  • Liver Enzymes

Interventions

DIETARY_SUPPLEMENT

Whole wheat muffin

Participants received Whole wheat muffin once a day

DIETARY_SUPPLEMENT

Whole wheat muffin enriched with raw banana flour (RBF) (contains 17.5g RBF)

Participants received Whole wheat muffin enriched with raw banana flour (RBF) (contains 17.5g RBF)

DIETARY_SUPPLEMENT

Whole wheat muffin enriched with raw banana flour (RBF) (contains 20g RBF)

Participants received Whole wheat muffin enriched with raw banana flour (RBF) (contains 20g RBF)

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-08
Primary Completion
2024-10-18
Completion
2024-10-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07145710 on ClinicalTrials.gov